NO910331L - Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. - Google Patents

Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Info

Publication number
NO910331L
NO910331L NO91910331A NO910331A NO910331L NO 910331 L NO910331 L NO 910331L NO 91910331 A NO91910331 A NO 91910331A NO 910331 A NO910331 A NO 910331A NO 910331 L NO910331 L NO 910331L
Authority
NO
Norway
Prior art keywords
promoter
recombinant plasmid
plasmid
prl
copper
Prior art date
Application number
NO91910331A
Other languages
English (en)
Other versions
NO910331D0 (no
Inventor
Walter Bodemer
Friedrich Scheiflinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO910331D0 publication Critical patent/NO910331D0/no
Publication of NO910331L publication Critical patent/NO910331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Et rekombinant plasmid inneholdende minst ett replikon (oril), minst én seleksjons-markør (sml), minst én promotor (prl) og DNA-sekvenser fra et koppervirusgenom som flankerer denne promotor, og en fler-funksjonen DNA-sekvenskassett anordnet på nedsiden av promtoren (prl), er fremstilt. Den flerfunksjonene DNA-sekvenskassett inneholder sekvenser som er komplementære til i handelen tilgjen-gelige primersekvenser som har vist sin nytte i praksis, et translasjonsinitieringskodon og flere restriksjons-endonuklease-kloyvingsseter og stopp-kodoner i alle tre rammer som folger etter dette translasjonsinitieringskodon. Det rekombinante plasmid er egnet til ekspresjon av fremmedproteiner i eukaryote vertscellers cytoplasma etter innsetting i et koppervirusgenom.
NO91910331A 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. NO910331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4002521A DE4002521A1 (de) 1990-01-29 1990-01-29 Rekombinantes plasmid

Publications (2)

Publication Number Publication Date
NO910331D0 NO910331D0 (no) 1991-01-29
NO910331L true NO910331L (no) 1991-07-30

Family

ID=6398977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910331A NO910331L (no) 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Country Status (8)

Country Link
EP (1) EP0443335A1 (no)
JP (1) JPH0515374A (no)
CA (1) CA2034564A1 (no)
CS (1) CS18991A2 (no)
DE (1) DE4002521A1 (no)
FI (1) FI910426A7 (no)
HU (1) HUT61331A (no)
NO (1) NO910331L (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073479A1 (en) 1999-05-28 2000-12-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
RU2180352C2 (ru) * 1999-11-24 2002-03-10 Государственный научный центр вирусологии и биотехнологии "Вектор" ФРАГМЕНТ ГЕНОМА ВИРУСА ОСПЫ КУР ШТАММА "К", СОДЕРЖАЩИЙ ГЕН ТИМИДИНКИНАЗЫ, РЕКОМБИНАНТНЫЕ ПЛАЗМИДНЫЕ ДНК pTK1FPV И pTK2FPV, СОДЕРЖАЩИЕ ЭТУ ПОСЛЕДОВАТЕЛЬНОСТЬ, И РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pINTFPV1, ОБЛАДАЮЩАЯ СПОСОБНОСТЬЮ ИНТЕГРИРОВАТЬСЯ В ГЕНОМ ВИРУСА ОСПЫ КУР

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2583429B1 (fr) * 1985-06-18 1989-11-03 Transgene Sa Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
ES2074422T3 (es) * 1987-03-20 1995-09-16 Immuno Ag Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
EP0404835A4 (en) * 1988-03-18 1991-05-08 Us Health Novel recombinant vaccinia virus expression vectors and method of selecting same

Also Published As

Publication number Publication date
NO910331D0 (no) 1991-01-29
HU910289D0 (en) 1991-08-28
JPH0515374A (ja) 1993-01-26
EP0443335A1 (en) 1991-08-28
HUT61331A (en) 1992-12-28
FI910426L (fi) 1991-07-30
FI910426A0 (fi) 1991-01-29
CS18991A2 (en) 1991-09-15
DE4002521A1 (de) 1991-08-01
FI910426A7 (fi) 1991-07-30
CA2034564A1 (en) 1991-07-30

Similar Documents

Publication Publication Date Title
DK0738327T3 (da) Vært-vektorsystem til anvendelse ved genterapi
ZA84377B (en) A polycistronic expression vector construction
DE3880468D1 (de) Rekombinante dns-expressionsvektoren.
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
AU3529189A (en) Modified baculovirus, method for preparing it and its use as an expression vector of genes
SE8004066L (sv) Plasmider, deras framstellning, deras anvendning som vektorer, dervid erhallna celler samt dessas anvendning
GB8424832D0 (en) Cdna clones coding
IE831211L (en) Cloning vectors for expression of exogenous protein
LU90770I2 (fr) luveris-lutropin alfa et ses d-riv-es pharmaceutiquement acceptables
NO834792L (no) Dna-sekvenser, plasmider som inneholder slike sekvenser, samt fremgangsmaater for fremstilling av slike sekvenser og plasmider
IL92264A0 (en) Process for the expression of recombinant genes
NO910331L (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
DK0431128T3 (da) Vektor, der koder for selvsamlende, defekte, ikke-selvopformerende viruspartikler
AU603331B2 (en) Expression vectors containing LAMBDA PL promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
IL88371A0 (en) Directed integration of genes into a plant genome and recombinant dna,expression vectors and host cells used therefor
ES8704209A1 (es) Un metodo para recuperar superoxido dismutasa eucariotica enzimaticamente activa o un analogo de la misma
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ